Trusted by:
A Georgetown University study shows that drinking purple grape juice not only has a direct effect on important biological functions like blood clotting, but it also appears to increase plasma levels of valuable antioxidants while decreasing production of a key free radical.
As Liberia rebuilds a health care system decimated by the 2014 Ebola outbreak, understanding precisely how far citizens live from health facilities and its impact on seeking care can help shape new strategies to improve health care delivery and reduce geographic disparities.
The visual and narrative arts can help physicians hone their observational skills 鈥� a critical expertise increasingly needed in today鈥檚 medicine, contends a Georgetown University Medical Center family medicine professor.
A new study suggests people who speak two languages have more gray matter in the executive control region of the brain.
In animal models, acupuncture appears to impact the same biologic pathways ramped up by pain and stress, analogous to what drugs do in humans. The researchers say their animal study provides the strongest evidence to date on the mechanism of this ancient Chinese therapy in chronic stress.
Neuroscientists have found in a small study that although a group of HIV+ older individuals scored 鈥渃ognitively normal鈥� in standard neuropsychology testing, a scan of their brains tells a different story.
The largest nationwide clinical trial to study high-dose resveratrol long-term in people with mild to moderate Alzheimer鈥檚 disease found that a biomarker that declines when the disease progresses was stabilized in people who took the purified form of resveratrol.
A new animal study shows that traumatic brain injury (TBI) affects the body as well as the brain and that treatment with hypertension drugs blocks the production of proteins related to inflammation.
Neuroscientists have uncovered the brain malady responsible for tinnitus and for chronic pain 鈥� the uncomfortable, sometimes agonizing sensations that persist long after an initial injury.
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson鈥檚 disease and Lewy body dementia in a small phase I clinical trial, report researchers at Georgetown University Medical Center in Washington. In addition, the drug, nilotinib (Tasigna庐 by Novartis), led to statistically significant and encouraging changes in toxic proteins linked to disease progression (biomarkers).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right